AbbVie Inc. Files 8-K on Financials and Senior Notes
Ticker: ABBV · Form: 8-K · Filed: 2025-07-03T00:00:00.000Z
Sentiment: neutral
Topics: debt, financials, notes
Related Tickers: ABBV
TL;DR
AbbVie dropped an 8-K detailing its debt structure, including notes due 2027-2031.
AI Summary
On July 3, 2025, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior notes, including those due in 2027, 2028, 2029, and 2031, with coupon rates ranging from 0.750% to 2.625%.
Why It Matters
This filing provides investors with an update on AbbVie's financial structure, specifically concerning its outstanding debt obligations through various senior notes.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Numbers
- 2027 — Senior Notes Maturity Year (Indicates a specific debt maturity date for AbbVie.)
- 2028 — Senior Notes Maturity Year (Indicates a specific debt maturity date for AbbVie.)
- 2029 — Senior Notes Maturity Year (Indicates a specific debt maturity date for AbbVie.)
- 2031 — Senior Notes Maturity Year (Indicates a specific debt maturity date for AbbVie.)
Key Players & Entities
- AbbVie Inc. (company) — Registrant
- July 3, 2025 (date) — Date of earliest event reported
- 0.750% (dollar_amount) — Coupon rate for Senior Notes Due 2027
- 2.625% (dollar_amount) — Coupon rate for Senior Notes Due 2028
FAQ
What is the purpose of this 8-K filing by AbbVie Inc.?
The 8-K filing on July 3, 2025, reports on AbbVie Inc.'s Results of Operations and Financial Condition, and includes Financial Statements and Exhibits.
What types of financial instruments are mentioned in the filing?
The filing mentions several series of Senior Notes, including those due in 2027, 2028, 2029, and 2031, with various coupon rates.
What is the earliest date reported in this filing?
The earliest event reported in this filing is dated July 3, 2025.
What is AbbVie Inc.'s state of incorporation and fiscal year end?
AbbVie Inc. is incorporated in Delaware and its fiscal year ends on December 31.
What are the coupon rates for the mentioned senior notes?
The filing lists coupon rates for senior notes including 0.750% (due 2027), 2.125% (due 2028), 2.625% (due 2028), 2.125% (due 2029), and 1.250% (due 2031).
From the Filing
0001551152-25-000034.txt : 20250703 0001551152-25-000034.hdr.sgml : 20250703 20250703130755 ACCESSION NUMBER: 0001551152-25-000034 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250703 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250703 DATE AS OF CHANGE: 20250703 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 251104682 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 8-K 1 abbv-20250703.htm 8-K abbv-20250703 0001551152 false 0001551152 2025-07-03 2025-07-03 0001551152 us-gaap:CommonStockMember exch:XNYS 2025-07-03 2025-07-03 0001551152 us-gaap:CommonStockMember exch:XCHI 2025-07-03 2025-07-03 0001551152 abbv:Sec0.750SeniorNotesDue2027Member exch:XNYS 2025-07-03 2025-07-03 0001551152 abbv:Sec2.125SeniorNotesdue2028Member exch:XNYS 2025-07-03 2025-07-03 0001551152 abbv:Sec2625SeniorNotesDue2028Member exch:XNYS 2025-07-03 2025-07-03 0001551152 abbv:Sec2125SeniorNotesDue2029Member exch:XNYS 2025-07-03 2025-07-03 0001551152 abbv:Sec1.250SeniorNotesdue2031Member exch:XNYS 2025-07-03 2025-07-03 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  _____________________________________________________ FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): July 3, 2025   ABBVIE INC. (Exact name of registrant as specified in its charter) Delaware   001-35565   32-0375147 (State or other Jurisdiction   (Commission File Number)   (IRS Employer of Incorporation)       Identification No.)  _____________________________________________________ 1 North Waukegan Road North Chicago ,  Illinois 60064-6400 (Address of principal executive offices)(Zip Code)   Registrant’s telephone number, including area code:  ( 847 ) 932-7900   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐                       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐                       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐                       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐                       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.01 Par Value   ABBV   New York Stock Exchange NYSE Texas 0.750% Senior Notes due 2027 ABBV27 New York Stock Exchange 2.125% Senior Notes due 2028 ABBV28 New York Stock Exchange 2.625% Senior Notes due 2028 ABBV28B